India, Oct. 23 -- Bollore SE (BOP.SG,BOL.PA) reported third-quarter 2026 revenue of 937 million euros, up 49% from 630 million euros a year earlier. The reported revenue included a negative 17 million... Read More
India, Oct. 23 -- Foremost Clean Energy Ltd. (FMST) agreed to sell a 31% interest in its GR and Blackwing properties to Denison Mines Corp. The deal includes forming two exploration joint ventures an... Read More
India, Oct. 23 -- Bristol Myers Squibb (BMY) presented interim results from the Phase 1 Breakfree-2 study of investigational zolacabtagene autoleucel (zola-cel) in patients with highly active relapsin... Read More
India, Oct. 23 -- Stocks moved mostly lower in early trading on Friday, extending the sell-off seen over the course of the previous session. Selling pressure has waned over the course of the session, ... Read More
India, Oct. 23 -- Bristol Myers Squibb (BMY) reported interim Phase 1 Breakfree-2 study results for investigational CAR T-cell therapy zolacabtagene autoleucel (zola-cel) in 66 patients with highly ac... Read More
India, Oct. 23 -- ORIC Pharmaceuticals (ORIC) presented clinical data for enozertinib, an investigational EGFR inhibitor, in patients with previously untreated non-small cell lung cancer (NSCLC) carry... Read More
India, Oct. 23 -- The University of Michigan released a report on Friday showing consumer sentiment in the U.S. deteriorated by far less than previously estimated in the month of October. The report ... Read More
India, Oct. 23 -- Friday, Munich Re (0KFE.L,MUV2.DE) announced its preliminary financial results for the third quarter, expecting a net profit of about 1.7 billion euros, exceeding the analysts' conse... Read More
India, Oct. 23 -- Friday, Ascom Holding AG (ASCN.SW) announced the completion of share capital reduction following the share buyback. Under the program, Ascom Holding AG repurchased 3 million registe... Read More
India, Oct. 23 -- Cumberland Pharmaceuticals Inc. (CPIX) reported results from its Phase 2a ASSIST-SSc trial evaluating oral ifetroban in patients with systemic sclerosis (SSc), with the study support... Read More